Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,356.50
+29.00 (1.25%)
Aug 14, 2026, 3:30 PM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 4.23 trillion as of August 14, 2026. Its market cap has increased by 42.04% in one year.
Market Cap
4.23T
Enterprise Value
4.57T
Revenue
2.27T
Ranking
n/a
PE Ratio
11.61
Stock Price
2,356.50
ChartMarket Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.23T, an increase of 378.60%. That is a compound annual growth rate of 4.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.23T | 12.70% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.41T |
| Otsuka Holdings | 6.32T |
| Daiichi Sankyo Company | 4.97T |
| Kyowa Kirin | 1.35T |
| Ono Pharmaceutical | 1.14T |
| Santen Pharmaceutical | 616.20B |
| JCR Pharmaceuticals | 64.19B |
| Perseus Proteomics | 2.67B |